Oct 2026· Biotechnic & Histochemistry· Vol 101, pp. 12 - 12· 0 citations· 5 references
TL;DR
This work applies a structure–property design strategy to develop next-generation hemicyanine scaffolds for deep-tissue PA imaging and introduces targeted modifications to red-shift absorption and enhance heat generation.
Abstract
Near-infrared (NIR) small-molecule dyes are promising contrast agents because NIR excitation enables deeper tissue penetration and lower background. Hemicyanine dyes offer a tunable donorπ–acceptor scaffold, but many show limited NIR absorption and inefficient nonradiative decay, reducing photoacoustic (PA) output (Gardner et al. 2021). Here, we apply a structure–property design strategy to develop next-generation hemicyanine scaffolds for deep-tissue PA imaging (Ding et al. 2023; MacCuaig et al. 2024). Starting from a xanthene-like hemicyanine platform featuring an electron-rich phenolic donor, we introduce targeted modifications to red-shift absorption and enhance heat generation (Brøndsted and Stains 2024). We investigate difluoro substitution on the cyclohexene/ polymethine bridge to tune electron distribution and stability, and O→S replacement to access thioxanthene analogs expected to further bathochromically shift absorption and suppress fluorescence (Brøndsted and Stains 2024). A modular synthesis yields a focused dye library with systematic donor/acceptor/bridge variation. Structures are confirmed by 1 H NMR, optical properties by UV–Vis and fluorescence spectroscopy, and PA performance by multispectral optoacoustic
Activatable NIR-II hemicyanine probes are crucial tools for high-contrast deep-tissue biomarker imaging. However, their development is constrained by an inherent dilemma: extending π-conjugation to narrow the energy gap inevitably compromises the fluorescence brightness in the activated state (dim on), while the strong...
Xing-Yu Wang, Qian Chen, Tuan-Wei Li et al.· Analytical Chemistry· 0 citations
NIR-II fluorescence/photoacoustic dual-modal imaging offers complementary advantages in sensitivity and penetration depth. However, its efficacy is compromised by aggregation, nonspecific binding, and background interference, which persist even with polymeric encapsulation. To address these limitations, we report her...
Xiao-Dong Zhang, Hui Bian, Yang-Ting Qiu et al.· Journal of the American Chem...· 0 citations
Second near-infrared (NIR-II; 1000 to 1700 nanometers) aggregation-induced emission luminogens (AIEgens) hold great promise for imaging-guided precision tumor phototherapy yet are limited by the intrinsic trade-off between fluorescence brightness and photothermal performance. Existing design strategies often yield comp...
Huan-Long Zheng, Tian-Tian Li, Tong Sun et al.· Science Advances· 0 citations
Specifically disrupting lipid droplets (LDs) is an effective strategy for ablating tumor cells through photodynamic therapy (PDT). However, most reported LD probes possess short excitation/emission wavelengths, limiting tissue penetration, and LD-targeted theranostic probes remain underdeveloped. In this work, we first...
Li Chen, Yu-Tong Wang, Jun Yang et al.· Journal of Medicinal Chemist...· 0 citations
Ultrabright fluorophores emitting in the second near-infrared (NIR-II, 1000–1700 nm) window are highly desirable for biomedical and optoelectronic applications but remain rare, because fluorescence brightness requires the simultaneous realization of a large absorption coefficient (ε) and a high photoluminescence quantu...
Xiao-Fei Miao, Ming-Xuan Jia, Wei-Yun Yao et al.· Science Advances· 0 citations
This work delivers a robust molecular design paradigm for non-radiative decay optimization, and for the first time establishes 1700 nm-excitable PAI nano-agents, paving the way for tissue high-quality biomedical imaging.
Long-Cai Liu, Yang Chen, Li-Ya Yu et al.· Nature Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.